• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Agenus Inc. (AGEN)

    -NasdaqCM
    3.93 Up 0.57(17.16%) 4:00PM EST
    |After Hours : 3.92 Down 0.01 (0.13%) 5:21PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:3.35
    Open:3.75
    Bid:3.90 x 300
    Ask:3.92 x 1500
    1y Target Est:6.50
    Beta:2.55
    Next Earnings Date:N/A
    Day's Range:3.59 - 3.96
    52wk Range:2.27 - 5.27
    Volume:2,852,437
    Avg Vol (3m):393,898
    Market Cap:246.03M
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGENUp 17.16%246.03M
    ABPIUp 16.67%314.14K
    DNDN 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):36.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.43
    Quarterly EPS Est (Dec-14) :-0.15
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback